Daniel G. Welch

Insider Reports History

Location
4611 University Dr, 4 University Place, Durham, NC
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel G. Welch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 32.7K $1.24M $37.98 May 15, 2025 Direct
Nuvation Bio Inc. Director Class A Common Stock 660K $1.08M $1.64 May 24, 2024 Direct
Structure Therapeutics Inc. Director Share Option (right to buy) 51.8K Jun 23, 2025 Direct
PROTHENA CORP PUBLIC LTD CO Director Stock Option (Right to Buy) 20.2K May 14, 2025 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 10.8K May 15, 2025 Direct
Nuvation Bio Inc. Director Stock Option (Right to Buy) 0 May 24, 2024 Direct
Seagen Inc. Director Common Stock 0 $229.00 Dec 14, 2023 by Trust
Seagen Inc. Director Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Non-Qualified Stock Option (right to buy) 0 Aug 28, 2023 Direct

Insider Reports Filed by Daniel G. Welch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GPCR Structure Therapeutics Inc. Jun 23, 2025 1 $0 4 Jun 25, 2025 Director
RARE Ultragenyx Pharmaceutical Inc. May 15, 2025 2 $0 4 May 19, 2025 Director
PRTA PROTHENA CORP PUBLIC LTD CO May 14, 2025 1 $0 4 May 16, 2025 Director
GPCR Structure Therapeutics Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
NUVB Nuvation Bio Inc. May 24, 2024 4 $1.11M 4 May 29, 2024 Director
PRTA PROTHENA CORP PUBLIC LTD CO May 15, 2024 1 $0 4 May 17, 2024 Director
PRTA PROTHENA CORP PUBLIC LTD CO Feb 21, 2024 1 $0 4 Feb 23, 2024 Director
PRTA PROTHENA CORP PUBLIC LTD CO Feb 21, 2024 0 $0 3 Feb 23, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 3 -$3.54M 4 Dec 15, 2023 Director
SGEN Seagen Inc. Aug 28, 2023 5 -$784K 4 Aug 29, 2023 Director
GPCR Structure Therapeutics Inc. Aug 3, 2023 3 $0 4 Aug 4, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
NUVB Nuvation Bio Inc. May 15, 2023 1 $0 4 May 17, 2023 Director
SGEN Seagen Inc. May 15, 2023 3 -$120K 4 May 16, 2023 Director
SGEN Seagen Inc. May 1, 2023 19 -$3.82M 4 May 3, 2023 Director
SGEN Seagen Inc. Apr 3, 2023 0 $0 4/A Apr 12, 2023 Director
SGEN Seagen Inc. Mar 15, 2023 5 -$642K 4 Mar 17, 2023 Director
SGEN Seagen Inc. Mar 13, 2023 23 -$4.88M 4 Mar 16, 2023 Director
GPCR Structure Therapeutics Inc. Feb 7, 2023 2 $0 4 Feb 9, 2023 Director
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2022 2 $0 4 Jun 28, 2022 Director
NUVB Nuvation Bio Inc. May 16, 2022 1 $0 4/A Jun 28, 2022 Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
SGEN Seagen Inc. Dec 31, 2021 2 $0 5 Feb 11, 2022 Director
NUVB Nuvation Bio Inc. Oct 29, 2021 1 $0 4 Nov 2, 2021 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director